|
⚲
|
| Keyboard |
| Supernus Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0001356576 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001356576] | |
| 10-Q | [0001356576] | |
| 3 | [0001356576] | |
| 4 | [0001356576] | |
| 5 | [0001356576] | |
| 8-K | [0001356576] | |
| SC 13D | [0001356576] | |
| SC 13G | [0001356576] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-18 | Sell | 6,838 | $49.55 | 338,823 |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-03-18 | Option exercise | 7,250 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-18 | Sell | 412 | $50.48 | 20,798 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-18 | Option exercise | 7,250 | $39.40 | 285,650 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-17 | Option exercise | 12,250 | $36.75 | 450,188 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-17 | Sell | 27,710 | $49.95 | 1,384,114 |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-03-17 | Option exercise | 15,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-03-17 | Option exercise | 22,750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-17 | Sell | 22,290 | $50.73 | 1,130,772 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-17 | Option exercise | 22,750 | $39.40 | 896,350 |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-03-17 | Option exercise | 12,250 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-17 | Option exercise | 15,000 | $38.60 | 579,000 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-16 | Sell | 15,886 | $50.49 | 802,084 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-16 | Option exercise | 4,250 | $29.61 | 125,842 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-16 | Option exercise | 18,000 | $32.20 | 579,600 |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 22,750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 5,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-16 | Sell | 34,114 | $50.18 | 1,711,841 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-16 | Option exercise | 22,750 | $36.75 | 836,062 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-16 | Option exercise | 5,000 | $27.94 | 139,700 |
| showing 20 of 200 most recent transactions | |||||